Diagnostic Medical Systems S.A.
ALDMS.PA · PAR
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.70 | 0.27 | 0.03 | -0.00 |
| FCF Yield | 0.00% | 6.92% | -6.11% | -5.55% |
| EV / EBITDA | 0.00 | -1.24 | 129.76 | -47.49 |
| Quality | ||||
| ROIC | 0.00% | 1.08% | -2.18% | -3.74% |
| Gross Margin | 0.00% | 81.49% | -2.34% | 869.78% |
| Cash Conversion Ratio | -1.91 | -0.67 | -0.06 | -0.52 |
| Growth | ||||
| Revenue 3-Year CAGR | 1.57% | 2.17% | -0.36% | -1.10% |
| Free Cash Flow Growth | 0.00% | 203.21% | 11.11% | 68.24% |
| Safety | ||||
| Net Debt / EBITDA | 0.00 | -0.64 | 66.98 | -17.96 |
| Interest Coverage | -7.33 | 0.19 | -2.17 | -4.54 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.30 | 1.58 | -0.47 |
| Cash Conversion Cycle | 0.00 | 110.06 | 57.23 | 724.30 |